Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5152/eurjrheum.2017.160073 http://scihub22266oqcxt.onion/10.5152/eurjrheum.2017.160073 C5473453!5473453!28638691     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Rheumatol 2017 ; 4 (2): 145-7 Nephropedia Template TP {{tp|p=28638691|t=2017. Catastrophic antiphospholipid syndrome treated with rituximab: A case report |pdf=|usr=}}{{28638691}} gab.com Text Catastrophic antiphospholipid syndrome treated with rituximab: A case report JO: Eur J Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=28638691 #FOAvip Catastrophic antiphospholipid syndrome (CAPS) is a rare and fatal condition that is characterized by diffuse venous and/or arterial thromboembolism within a short period of time and histopathological confirmation of small-vessel occlusion in at least one organ or tissue in the presence of positive antiphospholipid antibodies. Here we report the case of a 19-year-old woman with CAPS. During the first week of her hospitalization, she was diagnosed with CAPS on the basis of skin necrosis, pulmonary artery thrombosis, cerebral venous sinus thrombosis, and positive lupus anticoagulant. She was treated with corticosteroids, intravenous immunoglobulins, plasmapheresis, and anticoagulants. Forty days after the onset of CAPS, cutaneous lesions were recurred during skin surgery. She required a high dose of corticosteroids, intravenous immunoglobulins, and rituximab. No further thrombotic events occurred. Rituximab may be an effective treatment option for patients with CAPS. Twit Text FOAVip Catastrophic antiphospholipid syndrome treated with rituximab: A case report ????Eur J Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=28638691 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28638691 #FOAvip English Wikipedia <ref>{{Cite pmid|28638691}}</ref> Catastrophic antiphospholipid syndrome treated with rituximab: A case report #MMPMID28638691 Do?ru A; Ugan Y; ?ahin M; Karahan N; Tunç ?E Eur J Rheumatol 2017[Jun]; 4 (2): 145-7 PMID28638691show ga Catastrophic antiphospholipid syndrome (CAPS) is a rare and fatal condition that is characterized by diffuse venous and/or arterial thromboembolism within a short period of time and histopathological confirmation of small-vessel occlusion in at least one organ or tissue in the presence of positive antiphospholipid antibodies. Here we report the case of a 19-year-old woman with CAPS. During the first week of her hospitalization, she was diagnosed with CAPS on the basis of skin necrosis, pulmonary artery thrombosis, cerebral venous sinus thrombosis, and positive lupus anticoagulant. She was treated with corticosteroids, intravenous immunoglobulins, plasmapheresis, and anticoagulants. Forty days after the onset of CAPS, cutaneous lesions were recurred during skin surgery. She required a high dose of corticosteroids, intravenous immunoglobulins, and rituximab. No further thrombotic events occurred. Rituximab may be an effective treatment option for patients with CAPS. äCatastrophic antiphospholipid syndrome treated with rituximab: A case (epmc).pdf DeepDyve Pubget Overpricing